In the race for a safe and effective vaccine against coronavirus disease (COVID)-19, pharmaceutical formulation science plays a critical role throughout the development, manufacturing, distribution, and vaccination phases. The proper choice of the type of vaccine, carrier or vector, adjuvant, excipients, dosage form, and route of administration can directly impact not only the immune responses induced and the resultant efficacy against COVID-19, but also the logistics of manufacturing, storing and distributing the vaccine, and mass vaccination. In this review, we described the COVID-19 vaccines that are currently tested in clinical trials and provided in-depth insight into the various types of vaccines, their compositions, advantages, and potential limitations. We also addressed how challenges in vaccine distribution and administration may be alleviated by applying vaccinestabilization strategies and the use of specific mucosal immune response-inducing, noninvasive routes of administration, which must be considered early in the development process.

No abstract

A series of epoxy resin (EP)/octa(aminpropyl)silsesquioxane (POSS-NH 2 ) organic-inorganic hybrid composites (EP/POSS-NH 2 100/0, 95/5, 90/10, and 80/20 wt/wt) were prepared by melt casting and then curing. Viscoelastic and mechanical properties of these composites were studied by dynamic mechanical analysis and mechanical testing, respectively. Scanning electron microscopy was used to study of the micromorphologies of the composites and to elucidate the toughening mechanisms of POSS-NH 2 . POSS units incorporated into the epoxy network showed good compatibility with the resin matrix. Phase separation was not observed even at high POSS content (20 wt%). Incorporation of POSS macromer into the epoxy network after curing increased the glass transition temperature, slightly narrowed the temperature range widths of the glass transition, and lowered the intensities of their loss moduli peaks of the resultant composites. The glass transition temperature of EP/ POSS-NH 2 composites increased significantly with increasing POSS content at lower POSS content (<10 wt%), while increased slightly at higher POSS content. Both impact and flexural strengths of the hybrids reached their optimum values when 10 wt% content of POSS was introduced. POLYM. COMPOS., 28:175-179, 2007.

No abstract

Thioamide substitutions in peptides can be used as fluorescence quenchers in protease sensors and as stabilizing modifications of hormone analogs. To guide these applications in the context of serine proteases, we here examine the cleavage of several model substrates, scanning a thioamide between the P3 and P3′ positions, and identify perturbing positions for thioamide substitution. While all serine proteases tested were affected by P1 thioamidation, certain proteases were also significantly affected by other thioamide positions. We demonstrate how these findings can be applied by harnessing the combined P3/P1 effect of a single thioamide on kallikrein proteolysis to protect two key positions in a neuropeptide Y-based imaging probe, increasing its serum half-life to >24 h while maintaining potency for binding to Y1 receptor expressing cells. Such stabilized peptide probes could find application in imaging cell populations in animal models or even in clinical applications such as fluorescence-guided surgery.